Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1051-1058
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1051
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1051
Figure 2 Cumulative risk of metachronous head and neck squamous cell carcinoma after treatment of esophageal squamous cell carcinoma.
ESCC: Esophageal squamous cell carcinoma.
- Citation: Morimoto H, Yano T, Yoda Y, Oono Y, Ikematsu H, Hayashi R, Ohtsu A, Kaneko K. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(6): 1051-1058
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1051.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1051